Ozempic: Key differences Here are a few key differences between the drugs: Primary indication and FDA approval Contrave The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obesity), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Ozempic Ozempic is FDA-approved for: Controlling blood sugar in adults with type 2 diabetes Reducing the risk of serious heart problems, like heart attack, stroke, and death, in adults with type 2 diabetes and heart disease Reducing the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Although Ozempic isnt FDA-approved for weight loss, your healthcare provider may prescribe it off-label to help with weight management
Expanding middle-class populations influence 48% of demand growth, while digital health adoption accounts for 34% of patient engagement
Search strategy The PubMed, Scopus, and Web of Science (WoS) databases were searched using four combinations of Medical Subject Headings (MeSH) keywords (presented in Table 1 in the Results section)
Y., Yang, C
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications originally developed to help manage type 2 diabetes and are now widely recognized for their effectiveness in
